Nuvasive 

€36.8
3
+€0+0% Thursday 19:50

统计

当日最高
-
当日最低
-
52周高点
-
52周低点
-
成交量
-
平均成交量
-
市值
1.92B
市盈率
-107.61
股息率
-
股息
-

财报

8May预期
Q2 2021
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
0.44
0.49
0.55
0.6
预期EPS
不适用
实际EPS
不适用

财务

3.22%利润率
有盈利
2017
2018
2019
2020
2021
2022
1.14B营收
36.91M净利润

其他人也在关注

此列表基于在 Stock Events 上关注 NK8.F 的用户自选生成。这不是投资建议。

竞争对手

此列表为基于近期市场事件的分析。并非投资建议。

关于

NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. it provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; neuromonitoring systems, which use proprietary software-driven nerve detection and avoidance technology and its intraoperative neuromonitoring services and support; and specialized spinal implants to advance spinal fusion by enhancing the osseointegration and biomechanical properties of implant materials, including porous titanium and porous polyetheretherketone. The company also offers reline fixation system that facilitates the preservation and restoration of patient alignment; integrated global alignment platform consisting of Bendini spinal rod bending system that assists with manual rod manipulation for spinal fixation; Lessray that is an image enhancement platform designed to reduce radiation exposure in the operating room, as well as Pulse, which integrates multiple enabling technologies to enhance workflow, reduce variability, and increase the reproducibility of surgical outcomes; and various biologics that are used to aid in the spinal fusion or bone healing process. In addition, it provides MAGEC, a spinal bracing and distraction system, Precice limb lengthening system, and various other products for treating specialized orthopedic procedures; onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries; and cervical artificial disc technology for cervical total disc replacement procedures. The company sells its products to patients, surgeons, hospitals, and insurers through independent sales agents, directly employed sales personnel, and distributors in the United States and internationally. NuVasive, Inc. was incorporated in 1997 and is headquartered in San Diego, California.
Show more...
首席执行官
Mr. J. Christopher Barry
员工
2700
国家
美国
ISIN
US6707041058
WKN
000A0CAYR

上市

0 Comments

分享你的想法

FAQ

Nuvasive 今天的股价是多少?
NK8.F 当前价格为 €36.8 EUR,过去 24 小时上涨了 +0%。在图表上更密切关注 Nuvasive 股价表现。
Nuvasive 的股票代码是什么?
根据交易所不同,股票代码可能会有所不同。例如,在 交易所,Nuvasive 的股票以代码 NK8.F 进行交易。
Nuvasive 的市值是多少?
今天 Nuvasive 的市值为 1.92B
Nuvasive 去年的营收是多少?
Nuvasive 去年的营收为 1.14BEUR。
Nuvasive 去年的净利润是多少?
NK8.F 去年的净收益为 36.91MEUR。
Nuvasive 有多少名员工?
截至四月 29, 2026,公司共有2,700名员工。
Nuvasive 属于哪个行业?
Nuvasive从事于健康与养生行业。
Nuvasive 何时完成拆股?
Nuvasive 最近没有进行任何拆股。
Nuvasive 的总部在哪里?
Nuvasive 的总部位于 美国 的 San Diego。